Cell Therapy Technologies Market by Product, Process, Cell Type, End-User

Description

List of Tables

[188 Pages Report] The Cell Therapy Technologies Market size was estimated at USD 19.48 billion in 2023 and expected to reach USD 22.31 billion in 2024, at a CAGR 14.63% to reach USD 50.69 billion by 2030.

The cell therapy technologies market encompasses the products, services, and techniques employed in the research, development, production, and application of cellular therapies for therapeutic purposes. This includes a wide range of products such as consumables (reagents, enzymes, media), equipment (incubators, centrifuges), and services (cell therapy manufacturing). The field is primarily driven by advancements in regenerative medicine and immunotherapies that focus on repairing or replacing damaged tissue or cells to treat various diseases and disorders. Cell therapy technologies find applications in multiple areas such as oncology, cardiovascular disease treatment, orthopedic treatments, autoimmune disorders management, and inherited genetic disorders correction. The increasing global burden of chronic diseases such cancer, diabetes and cardiovascular disorders has accelerated the demand for innovative therapies. Additionally, favorable funding scenarios from government agencies and private investors have led to increased investments in research activities related to cell therapy development. However, the development and production of cell therapies often require complex procedures, which result in high associated costs, limiting their affordability and accessibility. A dearth of skilled workers may affect the rate at which advancements are made within the industry. Strategic alliances among biopharmaceutical companies and research institutes are rapidly expanding to overcome such challenges. Leveraging artificial intelligence (AI) and machine learning (ML) to optimize processes or identify new targets for cellular therapies and utilization of 3D bioprinting can further expand the scope of the industry.

KEY MARKET STATISTICS
Base Year [2023]	USD 19.48 billion
Estimated Year [2024]	USD 22.31 billion
Forecast Year [2030]	USD 50.69 billion
CAGR (%)	14.63%

Product: The advent of big data analytics tools driving the adoption of software tools for cell therapies

Consumables are essential components required during the various stages of cell therapy procedures, such as cell isolation, expansion, differentiation, and preservation. Key consumables include reagents, media, sera, growth factors, and other supplements needed to maintain optimal cell growth conditions. Equipment used in cell therapy technologies includes devices for isolation, purification, expansion, differentiation, or genetic modification of cells before administering them to patients. This category comprises bioreactors (single-use or reusable), centrifuges (for separating cells based on density), and flow cytometers (for identifying different types of cells). Cell therapy consumables and equipment enable scientists to grow new cells in the culture media for the purpose of drug development. Software solutions are critical to the effective management, analysis, and interpretation of data generated during cell therapy procedures. These software tools assist in monitoring quality control parameters, data analysis, and predicting treatment outcomes.

Process: Advancements in cell preservation technologies

Cell preservation is vital for maintaining the viability and functionality of cells during storage and transportation. The selection of preservation methods (such as cryopreservation or vitrification) and media depends on the cell type and intended application. Cell processing involves the isolation, modification, and concentration of therapeutic cells from various sources, such as bone marrow or adipose tissue. This step is crucial for achieving desired therapeutic effects while minimizing adverse reactions post-transplantation. Process monitoring ensures that critical quality attributes are maintained throughout manufacturing processes to meet regulatory requirements for cell-based therapies. Quality control is critical for evaluating the final therapeutic product and ensuring its safety, efficacy, and purity.

Cell type: Rising utilization of human cells in cell and gene therapies

Animal cells are widely used in various research areas, including drug discovery, disease modeling, toxicology studies, and basic science research. They serve as valuable tools in studying cellular processes and understanding complex biological systems. Moreover, animal cells play a significant role in bioprocessing for the production of recombinant proteins for therapeutics. The use of human cells in therapy has increased significantly due to advancements in stem cell research and regenerative medicine. Human-derived cells have become essential tools for personalized medicine approaches that aim to treat or prevent diseases by targeting specific patient profiles based on their unique genetic makeup.

End user: Government initiatives to propel investments in research institutes

In the healthcare and life science sector, the need for cell therapy technologies has been increasing due to factors such as personalized medicine, regenerative medicine, and the ongoing drive to improve patient outcomes. These technologies include advanced equipment and consumables used in cell isolation, expansion, analysis, storage, and transportation. Need-based preferences for healthcare and life science organizations range from clinical-grade reagents to efficient cell culture systems that promote rapid cell growth while maintaining high-quality standards. Research institutes primarily focus on understanding cellular processes, identifying new therapeutic targets, and developing innovative approaches for disease treatment using cell therapy technologies. Their needs include cutting-edge analytical and digital tools that provide accurate insights into cellular behavior under various conditions.

Regional Insights

The United States and Canada are major contributors to the growth of cell therapy technologies in the Americas. The presence of established biotechnology and pharmaceutical industries, along with numerous research institutions, drives innovation in this sector. The U.S. leads in patents filed for cell therapy innovations, which encourages investments from private and public entities. Furthermore, government initiatives and funding to propel research for oncology and genetic diseases have accelerated the development of gene and cell therapy technologies. In Europe, the European Union (EU) countries lead the market for cell therapy technologies with a strong focus on research and development. Several European biotech firms have made significant progress in clinical trials for advanced therapeutic medicinal products (ATMPs). China, Japan, and India are fast-growing markets for cell therapy technologies within the Asia Pacific region. China has established itself as a major player due to its considerable investment in biotech companies focused on cellular therapies. Chinese regulatory reforms have expedited approval processes for clinical trials, enabling rapid commercialization of cell therapies. Japan leads in regenerative medicine research primarily because of its government's proactive support for the sector.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Therapy Technologies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Therapy Technologies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Therapy Technologies Market, highlighting leading vendors and their innovative profiles. These include Anterogen Co., Ltd., Atara Biotherapeutics by FUJIFILM Corporation, Athersys, Inc., Becton, Dickinson and Company, Bluebird Bio, Inc., Bristol-Myers Squibb Company, Cellectis SA, Danaher Corporation, ElevateBio, Gamida Cell, GE Healthcare, Gilead Sciences, Inc., JCR Pharmaceuticals Co., Ltd., Johnson & Johnson Services, Inc., Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Novartis AG, Sartorius AG, STEMCELL Technologies Inc., Takeda Pharmaceutical Company Limited, Tego Science, Terumo Bct, Inc., Thermo Fisher Scientific, Inc., and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Cell Therapy Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Consumables
- Equipment
  - Cell Processing Equipment
  - Single-Use Equipment

Software

Process
- Cell Preservation, Distribution, & Handling
- Cell Processing
- Process Monitoring & Quality Control

Cell Type
- Animal Cells
- Human Cells
  - Differentiated Cells
  - Stem Cells
End-User
- Healthcare & Life Science
- Research Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell Therapy Technologies Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Therapy Technologies Market?

3. What are the technology trends and regulatory frameworks in the Cell Therapy Technologies Market?

4. What is the market share of the leading vendors in the Cell Therapy Technologies Market?

5. Which modes and strategic moves are suitable for entering the Cell Therapy Technologies Market?

Product Code: MRR-034230D3E636

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing incidence of chronic diseases and infections globally
  - 5.1.1.2. Rising GMP certifications for cell therapy production facilities
  - 5.1.1.3. Surge in government initiatives through investments in cell-based research
- 5.1.2. Restraints
  - 5.1.2.1. High costs associated with cell therapy technologies
- 5.1.3. Opportunities
  - 5.1.3.1. Ongoing focus on personalized medicine
  - 5.1.3.2. Emergence of iPSCs as an alternative to ESCs in technologies
- 5.1.4. Challenges
  - 5.1.4.1. Dearth of skilled professionals and stringent regulatory framework
5.2. Market Segmentation Analysis
- 5.2.1. Product: The advent of big data analytics tools driving the adoption of software tools for cell therapies
- 5.2.2. Process: Advancements in cell preservation technologies
- 5.2.3. Cell type: Rising utilization of human cells in cell and gene therapies
- 5.2.4. End user: Government initiatives to propel investments in research institutes
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Cell Therapy Technologies Market, by Product

6.1. Introduction
6.2. Consumables
6.3. Equipment
6.4. Software

7. Cell Therapy Technologies Market, by Process

7.1. Introduction
7.2. Cell Preservation, Distribution, & Handling
7.3. Cell Processing
7.4. Process Monitoring & Quality Control

8. Cell Therapy Technologies Market, by Cell Type

8.1. Introduction
8.2. Animal Cells
8.3. Human Cells

9. Cell Therapy Technologies Market, by End-User

9.1. Introduction
9.2. Healthcare & Life Science
9.3. Research Institutes

10. Americas Cell Therapy Technologies Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Cell Therapy Technologies Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Cell Therapy Technologies Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. Clade Therapeutics Announces the Acquisition of Gadeta B.V.
- 13.3.2. Startup Cellares adds USD 255 million as investors pour cash into cell therapy production
- 13.3.3. NewBiologix Launches with USD 50 million to Advance Novel Technology Platform for the Manufacturing of Gene and Cell Therapies
13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio